Due to the lack of approved medical access in the U.S., Americans are paying between $5,000 and $20,000 to travel to specialized clinics in Mexico for ibogaine treatments.

Mind-altering substances like psilocybin, LSD, MDMA, and ayahuasca and their therapeutic and cultural use.

First government-funded clinical trials of ibogaine for opioid addiction and PTSD, conducted by the FDA and VA.